WHO ICTRP trial
The efficacy and safety of Intralesional Diprospan injection and Oral…
ChiCTR-INR-17014081 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-INR-17014081 |
|---|---|
| Public title | The efficacy and safety of Intralesional Diprospan injection and Oral Propranolol for Infantile Hemagioma on the lip: A prospective study. |
| Scientific title | The efficacy and safety of Intralesional Diprospan injection and Oral Propranolol for Infantile Hemagioma on the lip: A prospective study. |
| Primary sponsor | Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | Infantile Hemangioma |
| Interventions | Intralesional Injection Group:Intralesional Injection;Propranolol Group:Propranolol |
| Registration date | Dec 21, 2017 |
| Target size | Intralesional Injection Group:10;Propranolol Group:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: